United States · FDA National Drug Code directory
LISINOPRIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0354_bebf037f-10f8-4e1f-a512-614f81deb891
- Product NDC
- 71335-0354
- Form
- TABLET
- Composition / generic term
- Lisinopril
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111101
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-0354-1) · 71335-0354-1
- 60 TABLET in 1 BOTTLE (71335-0354-2) · 71335-0354-2
- 90 TABLET in 1 BOTTLE (71335-0354-3) · 71335-0354-3
- 120 TABLET in 1 BOTTLE (71335-0354-4) · 71335-0354-4
- 10 TABLET in 1 BOTTLE (71335-0354-5) · 71335-0354-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →